LOUISVILLE, Ky., Feb. 19, 2026 /PRNewswire/ -- Breath Diagnostics, Inc., a leader in breath-based molecular diagnostics powered by patented microreactor capture technology, is pleased to announce that ...

P. aeruginosa is a highly adaptable bacterium and a major cause of hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP) cases, which can lead to further spread of infection, ...

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda ...

The Gates Foundation this year handed $6.5 million to Owlstone Medical, developer of handheld “breath biopsy” sample capture devices—including a $5 million equity investment and a $1.5 million grant ...

CAMBRIDGE, England--(BUSINESS WIRE)--Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy ® for applications in early disease detection and precision medicine, today announced it has ...

The MarketWatch News Department was not involved in the creation of this content. Study published in The Journal of Thoracic and Cardiovascular Surgery indicates OneBreath(TM) technology can help ...

For the past decade or so, a great deal of hype has surrounded the subject of breath-based diagnostic and monitoring devices for such conditions as cancer and asthma. Just last week, however, Xhale ...

Using cutting-edge breath sampling, scientists have achieved a breakthrough in diagnosing lower respiratory tract infections with an in vitro assay that could transform patient care in ICUs worldwide.

Israeli scientists have developed a gas sensor that can distinguish "mirror image" molecules in the air, a breakthrough with the potential to revolutionize medical diagnostics, food and beverage ...

Noze Inc. breathes a little easier with a new $5 million equity investment from the Bill & Melinda Gates Foundation to support the development of Diagnoze, a breath-based, hand-held diagnostic device.